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Leptin acts in the brain to prevent obesity. The under-
lying neurocircuitry responsible for this is poorly
understood, in part because of incomplete knowl-
edge regarding first-order, leptin-responsive neu-
rons. To address this, we and others have been
removing leptin receptors from candidate first-order
neurons. While functionally relevant neurons have
been identified, the observed effects have been
small, suggesting that most first-order neurons
remain unidentified. Here we take an alternative
approach and test whether first-order neurons are
inhibitory (GABAergic, VGAT+) or excitatory (gluta-
matergic, VGLUT2+). Remarkably, the vast majority
of leptin’s antiobesity effects are mediated by
GABAergic neurons; glutamatergic neurons play
only a minor role. Leptin, working directly on presyn-
aptic GABAergic neurons, many of which appear not
to express AgRP, reduces inhibitory tone to postsyn-
aptic POMC neurons. As POMC neurons prevent
obesity, their disinhibition by leptin action on presyn-
aptic GABAergic neurons probablymediates, at least
in part, leptin’s antiobesity effects.
INTRODUCTION
Leptin is secreted by adipocytes in proportion to fat stores
providing feedback on the status of lipid reserves (Friedman,
2009). Leptin circulates and binds its receptor (LEPR) in the brain
where it decreases food intake and promotes energy expendi-
ture (Myers et al., 2010). When fat stores are reduced, such as
by fasting, dieting, lipodystrophy, or uncontrolled type 1 dia-
betes, blood leptin levels fall and this stimulates hunger while
decreasing energy expenditure—physiologic adaptations aimed
at returning fat stores to normal. Genetic deficiency of leptin or its
receptor removes this adipostat signal, ‘‘misinforming’’ the
organism about its state of energy balance and abundant fat
stores. Consequently, extreme hyperphagia, reduced energy142 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.expenditure, and massive obesity result. Thus, circulating leptin,
by restraining food intake and maintaining energy expenditure,
prevents obesity.
The neurobiological mechanisms underlying these ‘‘antiobe-
sity’’ effects are unknown. Nevertheless, key components are
likely to reside in the arcuate nucleus as suggested by the
convergence of numerous lines of compelling research. First,
the neuropeptides aMSH (Smart et al., 2006; Yaswen et al.,
1999) and AgRP (Ollmann et al., 1997; Shutter et al., 1997) and
the neurons that express them (POMC and AgRP neurons which
are located primarily in the arcuate) (Bewick et al., 2005; Gropp
et al., 2005; Luquet et al., 2005; Xu et al., 2005) play key roles
in regulating body weight. Second, POMC neurons and AgRP
neurons project to brain regions likely to be important in regu-
lating body weight (important examples include the paraventric-
ular nucleus and the lateral parabrachial nucleus (Bagnol et al.,
1999; Elias et al., 1998; Haskell-Luevano et al., 1999; Wu et al.,
2009). Third, aMSH and AgRP agonize and antagonize, respec-
tively, melanocortin-4 receptors (MC4Rs) (Mountjoy et al., 1992;
Ollmann et al., 1997) and importantly, MC4Rs mediate marked
antiobesity effects (Balthasar et al., 2005; Huszar et al., 1997).
Because POMC and AgRP neurons are the sole sources of
MC4R ligands (and because MC4Rs play a critical role in regu-
lating energy balance), POMC and AgRP neurons must be play-
ing a similarly important role. Fourth, LEPRs are expressed by
most AgRP neurons and many POMC neurons (Baskin et al.,
1999a; Elias et al., 1999; Williams et al., 2010; Wilson et al.,
1999), and leptin, which promotes negative energy balance,
inhibits AgRP neurons and excites POMC neurons (Cowley
et al., 2001; Elias et al., 1999; Takahashi and Cone, 2005; van
den Top et al., 2004). In addition, leptin decreases and increases,
respectively, expression of the neuropeptide genes, Agrp and
Pomc (Baskin et al., 1999a, 1999b; Mizuno et al., 1998; Wilson
et al., 1999). These effects of leptin on neuronal activity and
neuropeptide gene expression are consistent with the catabolic
effects of leptin and the anabolic and catabolic natures, respec-
tively, of AgRP and POMC neurons (Bewick et al., 2005; Gropp
et al., 2005; Luquet et al., 2005; Xu et al., 2005) and their neuro-
peptides (Ollmann et al., 1997; Smart et al., 2006; Yaswen et al.,
1999). Fifth, AgRP neurons, which also release NPY and GABA,
send collaterals to POMC neurons, providing an additional
means by which leptin can stimulate (via disinhibition) POMC
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findings suggest the following model: leptin binds directly to
LEPRs on AgRP and POMC neurons, inhibiting AgRP neurons
and activating POMC neurons, and this accounts for its antiobe-
sity actions.
If this model is correct and if it is the sole mechanism by which
leptin regulates energy balance, then deletion of LEPRs on AgRP
and POMC neurons should result in massive obesity, similar to
that seen in mice with total lack of leptin action (i.e., Lepob/ob
mice and Leprdb/db mice). To investigate this, we generated
mice that lack LEPRs on POMC neurons (i.e., Pomc-Cre,
Leprlox/lox mice), on AgRP neurons (i.e., Agrp-Cre, Leprlox/lox
mice), and on both POMC and AgRP neurons (i.e., Pomc-Cre,
Agrp-Cre, Leprlox/lox mice) (Balthasar et al., 2004; Hill et al.,
2010; van de Wall et al., 2008). Of note, mice lacking LEPRs on
either POMC neurons or on AgRP neurons developed very mild
obesity (increase inbodyweight of5gat 2–3monthsold) (Balth-
asar et al., 2004; van de Wall et al., 2008). This effect was much
smaller than expected, especially when one compares this with
the 26 g increase in body weight in 10-week-old mice with global
deficiency of LEPRs (van de Wall et al., 2008). One possible
explanation for the smaller than expected effect is that deletion
of LEPRs in one class of neurons (for example, the POMC
neurons) might be compensated by increased leptin action on
the other class of neurons (for example, the AgRP neurons), or
vice versa. However, this was not the case because an additive
and still much smaller than expected effect was observed in
mice lacking LEPRs on both POMC and AgRP neurons (van de
Wall et al., 2008). In total, the above findings suggest that direct
leptin action on POMC and AgRP neurons plays a small role in
controlling energy balance and that there are likely to be other
first-order, leptin-responding neurons that contribute importantly
to leptin’s antiobesity actions.
Areas beyond the arcuate could mediate important actions of
leptin. Of note, LEPRs are present in many sites outside the
arcuate. Within the hypothalamus, LEPRs are found in the
ventromedial hypothalamus (VMH), the dorsomedial hypothal-
amus (DMH), the lateral hypothalamus (LH), and the ventral pre-
mammillary nucleus (PMv) (in addition to the arcuate); within the
midbrain in the ventral tegmental area and raphe; and within the
brainstem, in the parabrachial nucleus, periaqueductal gray, and
dorsal vagal complex (Elias et al., 2000; Figlewicz et al., 2003;
Fulton et al., 2006; Grill et al., 2002; Hommel et al., 2006; Lein-
ninger et al., 2009; Leshan et al., 2009; Mercer et al., 1996,
1998; Mu¨nzberg, 2008; Scott et al., 2009). Strong arguments
have been made that neurons outside the arcuate are well-posi-
tioned to play important roles in regulating appetite (Berthoud,
2002; Grill and Kaplan, 2002). Indeed, injection of leptin into brain
sites distant from the arcuate inhibit food intake (examples
include injections into the fourth ventricle (Grill et al., 2002) and
the lateral hypothalamus (Leinninger et al., 2009).
The VMH is a site of interest given that gene knockout of SF1
causes abnormal VMH development and obesity (Majdic et al.,
2002; Zhao et al., 2004). To investigate SF1 neurons, we gener-
ated Sf1-Cre, Leprlox/loxmice (Dhillon et al., 2006). These animals
developed a small increase in body fat and body weight (5 g
increase in body weight at 2–3 months old). Thus, as with LEPRs
on POMC and AgRP neurons, the effect of LEPRs on SF1neurons is small. Another group has obtained qualitatively similar
results regarding the role of LEPRs on SF1 neurons (Bingham
et al., 2008).
Based on the above, the list of genetically verified, body
weight-regulating, first-order, leptin-responsive neurons in-
cludes POMC (Balthasar et al., 2004), AgRP (van de Wall et al.,
2008), and SF1 neurons (Bingham et al., 2008; Dhillon et al.,
2006). Given this, and the realization that these neurons account
for only a portion of leptin’s effects (thus other neurons must also
be involved), it has been proposed that leptin action is mediated
by a distributed network of leptin-responsive neurons (Lein-
ninger and Myers, 2008; Myers et al., 2009; Scott et al., 2009).
With such a distributed model in mind, it is of interest to deter-
mine if any deeper logic underlies first-order, leptin-responsive
neurons and/or their mode of communication with energy
balance-regulating neurocircuits.
Because the obvious ‘‘first-order’’ candidates have already
been directly tested, a new approach is needed for narrowing
in on these ‘‘unidentified’’ first-order neurons. In the present
study we evaluate if leptin’s effects are mediated primarily by
excitatory (glutamatergic, VGLUT2+) or inhibitory (GABAergic,
VGAT+) neurons. This approach has two important features.
First, it casts a wider net and provides insight into the neuro-
transmitter identity of the neurons mediating leptin’s antiobesity
effects. Second, it provides information regarding the function of
the leptin-responsive neurons (excitatory versus inhibitory). With
this goal in mind, we have generated mice that express Cre
recombinase in either glutamatergic (Vglut2-ires-Cre knockin
mice) or GABAergic neurons (Vgat-ires-Cre knockin mice).
VGLUT2 is one of three synaptic vesicle glutamate transporters
(Takamori, 2006). VGLUT1 is expressed primarily by neurons in
the cortex while VGLUT3 is expressed by isolated, select groups
of neurons, none of which are in the hypothalamus. Conse-
quently, VGLUT2 is the transporter utilized by glutamatergic
neurons in the hypothalamus, thalamus, midbrain, and hindbrain
and thus it is relevant to our investigation of leptin-responsive
neurons. VGAT, on the other hand, is the only transporter
capable of importing GABA into synaptic vesicles; hence,
VGAT is expressed by all GABAergic neurons (Wojcik et al.,
2006). Through use of these Cre-expressing mice, we show
that the majority of leptin’s antiobesity effects are mediated by
inhibitory (GABAergic) neurons. We then build on this finding
and examine means by which leptin-responsive GABAergic
neurons engage obesity-preventing POMC neurons.
RESULTS
Generation of Vgat-ires-Cre and Vglut2-ires-Cre Mice
To ensure eutopic expression of Cre recombinase by VGAT- and
VGLUT2-expressing neurons, we inserted an ires-Cre cassette
by gene targeting just downstream of the endogenous Vgat
and Vglut2 stop codons, respectively (Figure 1A). The alleles
are used in the heterozygous state (i.e., Vglut2ires-Cre/+,
Vgatires-Cre/+) and do not have detectable effects on phenotype.
To confirm that Cre is eutopically expressed, we crossed
Vgat-ires-Cre and Vglut2-ires-Cre mice with lox-GFP reporter
mice (Novak et al., 2000) and processed brains for immunohisto-
chemical detection of GFP. As is evident from Figures 1B–1GNeuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc. 143
Figure 1. Generation of Vgat-ires-Cre and
Vglut2-ires-Cre Mice
(A) Mice expressing Cre recombinase under the
control of the endogenous Vgat and Vglut2 genes
were generated by inserting an ires-Cre cassette
after the Vgat and Vglut2 stop codons, respec-
tively.
(B–D) Immunohistochemistry for eGFP expression
in Vgat-ires-Cre, lox-GFP mice; brown staining
represents Cre activity.
(D) Enlargement of boxed region in (C).
(E–G) Immunohistochemistry for eGFP expression
in Vglut2-ires-Cre, lox-GFP mice; brown staining
represents Cre activity.
(G) Enlargement of boxed region in (F).
ARC, arcuate; BLA, basolateral amygdale; CeA,
central amygdale; CPu, caudate putamen; DMH,
dorsomedial hypothalamus; LOT, nucleus of the
lateral olfactory tract; PVN, paraventricular
nucleus; SCh, suprachiasmatic nucleus; TH, thal-
amus; VMH, ventromedial hypothalamus; ZI, zona
incerta.
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where it is expected (i.e., known to be composed primarily of
GABAergic or glutamatergic VGLUT2+ neurons) and is not
seen in sites where it is unexpected. Brain areas known to be
composed primarily of GABAergic cell bodies (see Figure S1B
for Vgat mRNA in situ hybridization and Supplemental Informa-
tion for detailed discussion and supporting references), which
are depicted in Figure 1, include the caudate putamen (CPu),
suprachiasmatic nucleus (SCh), central amygdaloid nucleus
(CeA), and zona incerta (ZI). GABAergic areas depicted in Fig-
ure S1A include, in addition to those previously mentioned, the
nucleus accumbens (ACB), lateral septum (LS), medial septum
(MS), reticular nucleus of the thalamus (Rt), substantia nigra
pars reticulata (SNr), and Purkinje cell layer of the cerebellum.
Brain areas known to be composed primarily of glutamatergic
(VGLUT2+) cell bodies (see Figure S1B for Vglut2 mRNA in situ
hybridization and Supplemental Information for detailed discus-144 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.sion and supporting references), which
are depicted in Figure 1, include the thal-
amus (TH), paraventricular nucleus (PVN),
nucleus of the lateral olfactory tract (LOT),
basolateral nucleus of the amygdala
(BLA), and ventromedial hypothalamus
(VMH). Glutamatergic (VGLUT2+) areas
depicted in Figure S1A, in addition to
those previously mentioned, include the
piriform cortex (PIR), posterior hypo-
thalamus (PH), ventral premammillary
nucleus (PMv), subthalamic nucleus
(STh), medial geniculate nucleus (MG),
reticulotegmental nucleus (RTg), pontine
gray (PG), external cuneate nucleus
(ECu), and lateral reticular nucleus (LRt).
Of note, the arcuate nucleus (ARC),
dorsomedial nucleus of the hypothal-
amus (DMH), and lateral hypothalamuscontain both glutamatergic and GABAergic neurons, with
GABAergic neurons predominating. A striking feature of Figure 1
and Figure S1A in addition to what has previously been
mentioned is the lack of Cre activity where it should not be found,
i.e., in areas where cell bodies of the opposing neurotransmitter
predominate. For example, in sections from Vglut2-ires-Cre
mice there is an absence of Cre activity in known GABAergic
sites (in Figure 1: CPu, SCh, CeA, and ZI; in Figure S1A: ACB,
LS, MS, Rt, and SNr) and in sections from Vgat-ires-Cre mice
there is an absence of Cre activity in known glutamatergic
sites (in Figure 1: TH, PVN, LOT, BLA, and VMH; in Figure S1A:
PIR, PH, PMv, STh, MG, RTg, PG, ECu, and LRt). In accordance
with this, sections from Vglut2-ires-Cre mice versus Vgat-
ires-Cre mice appear as ‘‘negative images’’ of each other.
These results are consistent with Cre being expressed in all
VGLUT2+ or VGAT+ neurons and demonstrate that Vglut2-ires-
Cre and Vgat-ires-Cre mice subdivide the brain into neurons
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Figure 2. Effect of Deleting LEPRs from VGAT+ and VGLUT2+ Neurons on Body Weight, Body Composition, and Food Intake
(A) Body weight curves of male and female mice with LEPR deleted from VGAT+ neurons (open boxes), VGLUT2+ neurons (closed triangles), or controls
(Leprlox/lox, closed circles). Data are presented as mean ± SEM. Compared to the Leprlox/lox controls, all values are significantly different except in weeks 4 and 7
for the Vglut2-ires-Cre, Leprlox/lox females (assessed by one-way ANOVA with Dunnett’s multiple comparison test of all groups compared to Leprlox/lox mice).
(B) Fat mass and lean mass of male and female Vgat-ires-Cre, Leprlox/lox mice (left) and Vglut2-ires-Cre, Leprlox/loxmice (right) at 10 weeks old were analyzed by
EchoMRI. Data are presented as mean ± SEM.*p < 0.05, ***p < 0.001, unpaired t test compared to Leprlox/lox controls.
(C) Food intake of Vgat-ires-Cre, Leprlox/loxmice (left) and Vglut2-ires-Cre, Leprlox/loxmice (right). Data are presented as mean ± SEM.***p < 0.001, unpaired t test
compared to Leprlox/lox controls.
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Leptin Action via Presynaptic GABAergic Neuronsthat are either excitatory (glutamatergic, VGLUT2+), inhibitory
(GABAergic), or neither.
Energy Balance in Vgat-ires-Cre, Leprlox/lox
and Vglut2-ires-Cre, Leprlox/lox mice
To generate study subjects, we mated Leprlox/lox mice with either
Vgatires-Cre/+, Leprlox/lox mice or Vglut2ires-Cre/+, Leprlox/lox mice.
From such matings, 50% of all offspring are controls (i.e.,Leprlox/lox mice) and 50% have deletion of LEPRs in either
GABAergic (Vgatires-Cre/+, Leprlox/lox mice) or glutamatergic (i.e.,
Vglut2ires-Cre/+, Leprlox/lox mice) neurons. Remarkably, deletion of
LEPRs in GABAergic neurons of both male and female mice re-
sulted in a massive increase in body weight (Figure 2A) and fat
mass (Figure 2B), whichwas associatedwithmarked hyperphagia
(Figure 2C). Deletion of LEPRs in glutamatergic neurons, on the
other hand, produced minimal effects (Figures 2A–2C). TheseNeuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc. 145
Figure 3. GABAergic-VGAT+ and Gluatama-
tergic-VGLUT2+ Nature of POMC and AgRP
Neurons
(A) Colocalization of hrGFP (POMC neurons) and
DsRed (GABAergic neurons) in the arcuate in
Vgat-ires-Cre, lox-tdTomato, POMC-hrGFP mice.
(B) Colocalization of the hrGFP (POMC neurons)
and DsRed (glutamatergic VGLUT2+ neurons) in
the arcuate in Vglut2-ires-Cre, lox-tdTomato,
POMC-hrGFP mice.
(C) Colocalization of the hrGFP (AgRP/NPY
neurons) and DsRed (GABAergic neurons) in the
arcuate in Vgat-ires-Cre, lox-tdTomato, NPY-
hrGFP mice.
Green denotes anti-hrGFP, magenta denotes
anti-DsRed, and white denotes hrGFP + DsRed.
Scale bar = 20 mm.
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VMH as neurons in this site are glutamatergic (Figure 1 and Tong
et al., 2007) and the magnitude of effect is similar to that seen in
Sf1-Cre, Leprlox/lox mice (Dhillon et al., 2006). As an additional
comparison group, we generated mice that are global knockouts
foragermline-deleted lox-Leprallele (i.e.,LeprD/Dmice) (FigureS2).
Of note, the weight gain seen in Vgat-ires-Cre, Leprlox/lox mice is
86% (in males) and 83% (in females) of that seen in mice with
total lack of LEPRs (LeprD/D mice). The weight gain seen in
Vglut2-ires-Cre, Leprlox/loxmice, on the other hand, is only a small
fraction of that seen in LeprD/D mice. These results demonstrate
that LEPRs on GABAergic neurons mediate the vast majority of
leptin’s antiobesity effects; in comparison, LEPRs on glutamater-
gic (VGLUT2+) neurons play only a small role.
To determine whether deletion of LEPRs in GABAergic or glu-
tamatergic (VGLUT2+) neurons had effects on glucose homeo-
stasis, we measured blood glucose and insulin levels (Table
S1). Vgat-ires-Cre, Leprlox/lox mice had significantly elevated
fed and fasted blood glucose and serum insulin levels, which is
consistent with the development of obesity-induced type 2 dia-
betes. In contrast, but consistent with the minimal increase in fat
stores, fed and fasted blood glucose levels were unchanged and
serum insulin levels were only slightly increased (fed state only) in
Vglut2-ires-Cre, Leprlox/lox mice.
Of the Known First-Order Neurons, Only AgRP Neurons
Are GABAergic
Previously established, functionally relevant, first-order leptin-
responsive neurons include POMC and AgRP neurons in the146 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.arcuate nucleus and SF1 neurons in the
VMH (Balthasar et al., 2004; Dhillon
et al., 2006; van de Wall et al., 2008) and
possibly serotonin neurons in the raphe
(Yadav et al., 2009). An important ques-
tion is which, if any, of these neurons
are GABAergic as determined by Cre
activity in Vgat-ires-Cre mice and conse-
quently contribute to the obesity pheno-
type of Vgat-ires-Cre, Leprlox/lox mice.As previously mentioned, SF1 neurons are glutamatergic (Fig-
ure 1 and Tong et al., 2007). In support of this, no GABAergic
neurons were found in the VMH (Figure 1). To determine if
POMC neurons are GABAergic or glutamatergic and to confirm
that AgRP neurons are GABAergic (Cowley et al., 2001; Tong
et al., 2008), we used immunodetectable hrGFP expressed
from POMC-hrGFP (Parton et al., 2007) and NPY-hrGFP (van
den Pol et al., 2009) BAC transgenes to identify POMC and
AgRP neurons and colocalized this with Cre activity (tdTomato,
as described below). Note that NPY and AgRP are coexpressed
in the arcuate nucleus (van den Pol et al., 2009). GABAergic
(VGAT+) and glutamatergic (VGLUT2+) neurons were identified
by immunodetectable tdTomato in Vgat-ires-Cre, lox-tdTomato
mice and Vglut2-ires-Cre, lox-tdTomato mice, respectively (lox-
tdTomato, Ai9; Madisen et al., 2010). Of note, essentially no
POMC neurons (<1%) were VGAT+ (Figure 3A) and 10% of
POMC neurons were VGLUT2+ (Figure 3B). AgRP neurons, as
expected, were GABAergic (Figure 3C). It is important to note,
however, that AgRP neurons represent only a subset of all
GABAergic neurons in the arcuate (Figure 3C). Also of note,
POMC neurons, which are not GABAergic, are situated in
a dense background of GABAergic neurons (Figure 3A). Finally,
serotonin neurons in the raphe (as identified by immunohisto-
chemistry for TpH), do not express Cre activity in Vgat-ires-Cre
mice (Figure S3). Thus, AgRP neurons, but not POMC or SF1
neurons, are GABAergic and therefore are the only previously
established first-order neurons that contribute directly to the
obesity seen in Vgat-ires-Cre, Leprlox/lox mice. However, as
previously discussed, the contribution of LEPRs on AgRP
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Figure 4. Leptin-Induced pSTAT3 Expression in GABAergic and Glutamatergic-VGLUT2+ Neurons with and without LEPRs
(A–F) Double immunohistochemical staining for pSTAT3 and eGFP in the arcuate, DMH, and NTS/DMV from leptin-injected Vgat-ires-Cre, Lepr+/+, lox-GFPmice
(with LEPRs intact, A–C) and Vgat-ires-Cre, Leprlox/lox, lox-GFP mice (with LEPRs deleted from GABAergic neurons, D–F).
(G–N) Double immunohistochemical staining for pSTAT3 and eGFP in the arcuate, VMH, PMv, and NTS/DMV from leptin-injected Vglut2-ires-Cre,
Lepr+/+, lox-GFP mice (with LEPRs intact, G–J) and Vglut2-ires-Cre, Leprlox/lox, lox-GFP mice (with LEPRs deleted from glutamatergic VGLUT2+ neurons, K–N).
Green denotes anti-eGFP, magenta denotes anti-pSTAT3, and white denotes eGFP + pSTAT3. Scale bar = 20 mm.
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Leptin Action via Presynaptic GABAergic Neuronsneurons to regulation of energy balance is small (van de Wall
et al., 2008). Thus, the majority of leptin’s antiobesity must be
mediated by previously uncharacterized first-order leptin-
responsive GABAergic neurons.
Colocalization of LEPRs with GABAergic
and Glutamatergic Neurons
Given the above, a key question becomes the location of leptin-
responsive GABAergic neurons. To address this, we colocalized
LEPRactivity, asassessedby leptin-inducibleSTAT3phosphory-
lation, with Cre activity in Vgat-ires-Cre and Vglut2-ires-Cre,
lox-GFP reporter mice, with or without neuron-specific deletion
of LEPRs. Note that leptin-inducible P-STAT3 is a robust
means of detecting LEPR activity (Mu¨nzberg et al., 2004). Leptin
was injected (4mg/kg bodyweight i.p.) intomice that were fasted
overnight and 1 hr later brains were removed and assessed for
P-STAT3 and GFP expression. With regard to GABAergic
neurons, in control mice, P-STAT3 colocalized with GFP only in
the arcuate (Figure 4A), the DMH (Figure 4B), and in the lateral
hypothalamus (not shown). In the dorsal vagal complex (NTS/
DMV), all P-STAT3 expression was detected in non-GABAergic
neurons (Figure 4C). When LEPRs were deleted from
GABAergic neurons, all colocalization disappeared; residual
P-STAT3 was restricted to non-GABAergic neurons (Figures4D–4F). Thus, leptin-responsive GABAergic neurons are located
in the arcuate, the DMH, and the lateral hypothalamus.
With regard to glutamatergic (VGLUT2+) neurons, in control
mice, P-STAT3 colocalized with GFP only in the arcuate (small
number of neurons, Figure 4G), the VMH (Figure 4H), the PMv
(Figure 4I), and in the NTS/DMV (Figure 4J). When LEPRs were
deleted from glutamatergic neurons, colocalization disappeared
in the arcuate (Figure 4K) and in the VMH, PMv, and NTS/DMV,
all P-STAT3 signal was lost (Figures 4L–4N). These findings
indicate that leptin-responsive glutamatergic neurons are
located primarily in the VMH, the PMv, and the NTS/DMV (with
a smaller number also found in the arcuate), and of note, in the
VMH, PMv, and NTS/DMV, 100% of LEPR-expressing neurons
are glutamatergic.
Acute In Vitro Leptin Regulation of GABAergic Tone
to POMC Neurons
POMC neurons play a critical role in preventing obesity as evi-
denced by massive weight gain in mice lacking aMSH (Smart
et al., 2006; Yaswen et al., 1999), its receptor, MC4R (Balthasar
et al., 2005; Huszar et al., 1997), and in mice with ablation of
POMCneurons (Xuet al., 2005).Given this,weexaminedwhether
POMC neurons are downstream of leptin-responsive GABAergic
neurons. Specifically, we recorded inhibitory postsynapticNeuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc. 147
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Figure 5. Effects of Leptin Addition on
sIPSC Frequency in POMC Neurons
(A) Left: Time course of effects of 100 nM leptin
(blue squares) or of no additions (pink circles) on
sIPSC frequency in POMC neurons from control
(Leprlox/lox) mice. Data are presented as mean ±
SEM. Right: Example traces of sIPSCs recorded
from a POMC neuron just before (i) and after 25–
30 min of leptin addition (ii).
(B) Effects of 25–30 min of leptin treatment on
sIPSC frequency, expressed as percent of base-
line (prior to leptin addition) in POMC neurons from
Leprlox/lox (control) mice, Vgat-ires-Cre, Leprlox/lox
mice, AgRP-ires-Cre, Leprlox/loxmice, and POMC-
Cre, Leprlox/lox mice and also from Vgatlox/lox
(control) mice and AgRP-ires-Cre, Vgatlox/lox mice
(lacking VGAT in AGRP neurons). Data are pre-
sented as mean ± SEM. **p < 0.01, ***p < 0.001,
****p < 0.0001, paired t test for effect of leptin
versus baseline (see Supplemental Experimental
Procedures for details on how percent baseline
was determined).
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Leptin Action via Presynaptic GABAergic Neuronscurrents (IPSCs) in POMC neurons (visualized with the POMC-
hrGFPBAC transgene) and assessedeffects of leptin.Of interest,
a prior study with 200 mm thick coronal slices found that leptin
reduced IPSC frequency in POMC neurons by 25% in one-third
of POMC neurons and this was attributed to AgRP/NPY
GABAergic neurons (Cowley et al., 2001). In our studies, we
prepared thicker slices (300mm), positing that thismight preserve
more connections between the GABAergic and POMC neurons.
In Figures 5, 6, and 7, we report effects on all neurons tested.
Addition of leptin decreased spontaneous IPSC (sIPSC)
frequency in POMC neurons by 40% (Figures 5A and 5B). This
effect was not dependent upon action potentials because in
the presence of tetrodotoxin (TTX) leptin reduced miniature
IPSC (mIPSC) frequency to a similar extent (Figure S4A). We
and others (Cowley et al., 2001; Pinto et al., 2004) have observed
that frequency and amplitude of sIPSCs in POMC neurons are
minimally affected by the addition of TTX, demonstrating that
most sIPSCs in POMC neurons in the context of brain slice prep-
arations originate from spontaneous vesicle fusion events in
presynaptic GABAergic neurons. Unlike the situation in POMC
neurons, leptin failed to reduce sIPSC frequency in AgRP
neurons (visualized with the NPY-hrGFP BAC transgene) (Fig-148 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.ure S4B), indicating that leptin-mediated
suppression of IPSCs is not a generalized
phenomenon. Of interest, leptin’s inhibi-
tory effect on IPSCs in POMC neurons
was absent in Vgat-ires-Cre, Leprlox/lox
mice and persisted unaffected in
Pomc-Cre, Leprlox/lox mice (Figure 5B),
demonstrating that LEPRs on presyn-
aptic GABAergic neurons, and not post-
synaptic POMC neurons, mediate this
response. We next evaluated the role of
LEPRs on AgRP neurons that, as
mentioned above, are GABAergic and
are thought to be in synaptic contactwith POMC neurons (Cowley et al., 2001). Of note, in mice lack-
ing LEPRs on AgRP neurons, leptin reduced IPSC frequency in
POMC neurons by 31%, representing a small attenuation of
the inhibitory response (40%) noted above in control mice.
This suggests that the majority of leptin’s effect is mediated
by LEPRs on ‘‘non-AgRP’’ GABAergic neurons. To confirm
a prominent role for non-AgRP GABAergic neurons, we utilized
mice in which AgRP neurons are unable to release GABA
(Agrp-ires-Cre, Vgatlox/lox mice; Tong et al., 2008). In this case,
all IPSCs originate exclusively from non-AgRP GABAergic
neurons. Of note, leptin’s inhibitory effect on IPSC frequency
was still present (Figure 5B), establishing an important role for
non-AgRP GABAergic neurons. To summarize, addition of leptin
to brain slices reduces IPSC frequency in POMC neurons and
this effect is mediated by LEPRs on presynaptic GABAergic
neurons, the majority of which appear to be non-AgRP
GABAergic neurons.
Long-Term In Vivo Leptin Regulation of GABAergic Tone
to POMC Neurons
We next evaluated if manipulation of LEPRs, in vivo, altered
GABAergic tone to POMC neurons. Of note, a previous study
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Figure 6. Effects of Deleting LEPRs Glob-
ally, from GABAergic Neurons, from AgRP
Neurons or from POMC Neurons on Inhibi-
tory Tone to POMC Neurons
(A) Summary of sIPSC and mIPSC frequency
(top left) and amplitude (bottom left) in POMC
neurons from Leprlox/lox (control) mice, Vgat-ires-
Cre, Leprlox/lox mice, LeprD/D mice, POMC-Cre,
Leprlox/lox mice, and AgRP-ires-Cre, Leprlox/lox
mice. Data are presented as mean ± SEM. **p <
0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA
with Dunnett’s multiple comparison test of all
groups compared to Leprlox/lox mice. Top right:
Example traces of sIPSCs recorded from POMC
neurons of a Leprlox/lox (control) mouse and a Vgat-
ires-Cre, Leprlox/lox mouse. Bottom right: Cumu-
lative probability distribution of mIPSC amplitudes
from POMC neurons showing a significant right-
ward shift in Vgat-ires-Cre, Leprlox/lox mice
compared to Leprlox/lox (control) mice.
(B) Summary of membrane potential and firing rate
of POMC neurons from Leprlox/lox (control) mice
and Vgat-ires-Cre, Leprlox/loxmice before and after
the addition of the GABAA receptor blocker,
picrotoxin. Data are presented as mean ± SEM.
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Leptin Action via Presynaptic GABAergic Neuronsreported that mice lacking leptin (Lepob/ob mice) have a marked
increase in IPSC frequency in POMC neurons (Pinto et al., 2004).
In agreement with this, we observed that mice with a global lack
of LEPRs (LeprD/D mice) have a large increase in sIPSC and
mIPSC frequency in POMC neurons (Figure 6A) and also in
amplitude. This latter effect on amplitude appears to occur in
Lepob/ob mice as well (Pinto et al., 2004). In addition, we
observed an equally large increase in IPSC frequency and ampli-
tude in POMC neurons from Vgat-ires-Cre, Leprlox/lox mice but
found no increase in POMC neurons from Pomc-Cre, Leprlox/lox
mice (Figure 6A), demonstrating that deficient leptin signaling
in presynaptic GABAergic neurons, but not postsynaptic
POMC neurons, increases inhibitory tone in POMC neurons.
This effect appears not to be caused by deletion of LEPRs
from AgRP neurons because no increase in IPSC frequency or
amplitude was observed in POMC neurons from AgRP-ires-
Cre, Leprlox/lox mice (Figure 6A).
Deletion of LEPRs in VGAT+ neurons did not increase IPSC
frequency or amplitude in AgRP neurons—while not statisticallyNeuron 71, 142–significant, IPSC frequency in AgRP
neurons actually tended to decrease in
Vgat-ires-Cre,Leprlox/loxmice (FigureS5A).
Furthermore, deletion of LEPRs in gluta-
matergic (VGLUT2+) neurons did not
affect excitatory postsynaptic currents
(sEPSCs and mEPSCs) in POMC neurons
(Figure S5B). In summary, deficiency of
leptin signaling in presynaptic, non-AgRP
GABAergic neurons, but not postsynaptic
POMC neurons, selectively increases
inhibitory tone in POMC neurons.
To determine if POMC neurons are
affected by this increased GABAergictone, we assessed their membrane potential and firing rate. In
comparison with neurons from control mice, POMC neurons
from Vgat-ires-Cre, Leprlox/lox mice tended to be hyperpolarized
(62.1 ± 1.94 mV compared with 57.8 ± 2.8 mV in control
mice; Figure 6B, left panel) and consistent with this, addition
of the GABAA receptor blocker picrotoxin (PTX) in Vgat-ires-
Cre, Leprlox/lox mice produced a greater degree of depolariza-
tion. PTX addition increased membrane potential by 6.4 ±
0.97 mV in Vgat-ires-Cre, Leprlox/lox mice compared with only
3.2 ± 1.01 mV in control mice (p < 0.05, t test). In agreement
with this, their firing rate was markedly reduced, 0.32 ±
0.11 Hz in Vgat-ires-Cre, Leprlox/lox mice compared with
1.81 Hz ± 0.37 in control mice (p = 0.01, t test; Figure 6B, right
panel) and this reduction was markedly attenuated by PTX.
PTX addition increased firing rate by 11.6 ± 6.2-fold in Vgat-
ires-Cre, Leprlox/lox mice and by only 1.2 ± 0.1-fold in control
mice (p = 0.01, Mann-Whitney test). These findings support
the view that deficiency of leptin signaling in presynaptic
GABAergic neurons inhibits the activity of POMC neurons.154, July 14, 2011 ª2011 Elsevier Inc. 149
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Figure 7. Effects of Fasting on sIPSC
Frequency and Amplitude in POMCNeurons
(A) Summary of the effects of fasting on sIPSC
frequency (left) and amplitude (right) in POMC
neurons of fed Leprlox/lox mice, fasted Leprlox/lox
mice, and fasted + saline- or fasted + leptin-in-
jected Leprlox/lox mice. Data are presented as
mean ± SEM. ***p < 0.001, one-way ANOVA with
Dunnett’s multiple comparison test of all groups
compared to fed Leprlox/lox mice.
(B) Summary of the effects of fasting on sIPSC
frequency (left) and amplitude (right) in POMC
neurons of fed and fasted Vgat-ires-Cre, Leprlox/lox
mice. Data are presented as mean ± SEM. ***p <
0.001, ****p < 0.0001, t test compared to fed Vgat-
ires-Cre, Leprlox/lox mice.
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Leptin Action via Presynaptic GABAergic NeuronsPhysiologic In Vivo Leptin Regulation ofGABAergic Tone
to POMC Neurons
We next evaluated whether a physiologic reduction in circulating
leptin, as occurs with fasting (Ahima et al., 1996), also increases
inhibitory input to POMCneurons. This is a key question because
the marked effects observed in Figure 6, while suggestive of
important regulation, might be seen only with ‘‘unphysiologic,’’
total absence of leptin signaling. Our studies described below
were motivated by a prior study in which fasting markedly
increased the firing rate of AgRP neurons (which are
GABAergic), an effect that was prevented by leptin treatment
3 hr prior to sacrifice (Takahashi and Cone, 2005). Of interest,
we found that fasting for 24 hr produced a marked increase in
sIPSC frequency and amplitude in POMC neurons (Figure 7A).
Importantly, these fasting-mediated effects were completely
prevented by injection of leptin (4 mg/kg), but not by saline, 3 hr
prior to sacrifice. Complete prevention of the fasting-stimulated
increase in IPSCs by leptin treatment is consistent with the view
that increased inhibitory tone caused by fasting is indeed due to
the fasting-mediated fall in leptin. We then assessed the effects
of fasting in mice lacking LEPRs on GABAergic neurons (Vgat-
ires-Cre, Leprlox/lox mice). Of note, fasting in these mice failed
to increase sIPSC frequency and amplitude (Figure 7B), which
as noted earlier are increased in the fed state compared with
control mice (Figure 6A). Amplitude not only failed to increase
but actually decreased with fasting in Vgat-ires-Cre, Leprlox/lox
mice, which is a paradoxical response presumably unmasked150 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.by the absence of leptin signaling. To
summarize, a physiologic decrease in cir-
culating leptin (induced by fasting in this
case) causes a marked increase in inhibi-
tory tone to POMCneurons and this effect
is probably mediated by decreased leptin
action on presynaptic GABAergic
neurons.
DISCUSSION
Despite intensive investigation, the neu-
ronal, subcellular, and molecular mecha-
nisms responsible for leptin’s antiobesityeffects are incompletely understood. While strong evidence
suggests a role for AgRP and POMC neurons in the arcuate, it
is unclear to what degree and by what means (directly or indi-
rectly) leptin engages these functionally important neurons.
Uncertainty about the direct neuronal targets of leptin (i.e., the
first-order, leptin-responsive neurons) has been a key obstacle.
The elusive nature of these first-order neurons combined with
other findings suggests the possibility that leptin action occurs
through a distributed network of leptin-responsive neurons. If
this is so, it then becomes important to establish whether any
deeper organizing principles underlie leptin-responsive first-
order neurons and their integration with body weight-regulating
neurocircuitry.
As part of a search for higher order, we have determined the
inhibitory versus the excitatory nature of leptin-responsive,
body weight-regulating neurons. Specifically, we used Vgat-
ires-Cre and Vglut2-ires-Cre knockin mice to manipulate LEPR
expression onGABAergic (VGAT+) and glutamatergic (VGLUT2+)
neurons and then tested for effects on energy balance. Remark-
ably, we find that leptin’s antiobesity effects are mediated
predominantly by GABAergic (VGAT+) neurons and that gluta-
matergic (VGLUT2+) neurons play only a small role. Importantly,
this raises the likely possibility that modulation of GABAergic
output is a key aspect of leptin action. Consistent with this, we
find by using multiple approaches that leptin action on presyn-
aptic GABAergic neurons markedly decreases inhibitory tone
to postsynaptic POMC neurons. This regulation was observed
Neuron
Leptin Action via Presynaptic GABAergic Neuronsby using the following paradigms: (1) addition of leptin in vitro
(Figure 5), (2) removal of leptin signaling selectively from presyn-
aptic GABAergic neurons in vivo (Figure 6), and (3) importantly,
with physiologic reductions in circulating leptin brought about
by fasting (Figure 7). Given the previously established role of
POMC neurons in preventing obesity (Smart et al., 2006; Xu
et al., 2005; Yaswen et al., 1999), these effects of leptin on
presynaptic GABAergic neurons provide a basis for leptin’s
antiobesity effects. Of note, indirect regulation of POMC neurons
by leptin reconciles the known important role of POMC neurons
in regulating body weight with the relatively unimportant role
played by direct leptin action on POMC neurons (Balthasar
et al., 2004; Hill et al., 2010; van de Wall et al., 2008). While in
our studies we have focused on POMC neurons as the down-
stream target of leptin-responsive GABAergic neurons, it is
certainly possible and perhaps likely that other antiobesity
neurons are similarly disinhibited by leptin action on presynaptic
GABAergic neurons. This will need to be tested as other antiobe-
sity neurons are identified. Given the above-mentioned findings,
GABAergic output appears to be an important, direct target of
leptin action.
Identity and Location of Leptin-Responsive GABAergic
Neurons
By using leptin-inducible P-STAT3 and GFP reporter expression
(in Vgat-ires-Cre mice) to colocalize LEPRs and GABAergic
neurons, we observed that LEPR-expressing GABAergic neu-
rons are located in the arcuate, the DMH, and the lateral hypo-
thalamus. Consequently, LEPR-expressing GABAergic neurons
in one, two, or all three of these sites mediate leptin’s antiobesity
effects. At present, our results do not allow us to rule in or out any
one site or any combination of these sites. Nevertheless, for
reasons listed below, we favor an important role for neurons in
the arcuate. First, LEPR-expressing arcuate neurons have
unparalleled access to circulating leptin (Faouzi et al., 2007).
Second, the arcuate has many GABAergic neurons, a small frac-
tion of which are AgRP neurons (Figure 3C and Acuna-Goycolea
et al., 2005; Horvath et al., 1997; Ovesjo¨ et al., 2001). Third,
POMC neurons, which are key targets of leptin-responsive
GABAergic neurons (Figures 5–7 and Cowley et al., 2001), are
located within the arcuate, surrounded by a dense population
of GABAergic neurons (Figure 3A). Fourth, neurons in the arcuate
make many local connections (Matsumoto and Arai, 1978; van
den Pol and Cassidy, 1982), providing the apparatus for local
regulation of POMC neurons. One previously defined local
circuit, likely to be physiologically important, is that between
AgRP neuron collaterals and POMC neurons (Cowley et al.,
2001; Horvath et al., 1992). As discussed below, we postulate
that this is just one of many local leptin-responsive GABAergic
inputs to POMC neurons.
Role of AgRP GABAergic Neurons versus Other
GABAergic Neurons
An earlier study (Cowley et al., 2001) established that leptin
reduces the frequency of IPSCs in POMC neurons (25% reduc-
tion in one-third of POMC neurons). The source of the reduced
GABAergic input was attributed to AgRP neurons (which also
express NPY). In the present study, we confirm leptin’s inhibitoryeffect on IPSC frequency, but, of interest, note a larger effect
(40% inhibition in all POMC neurons), perhaps because of our
use of thicker brain slices (300 mm versus 200 mm). A key
outcome of that prior study was the compelling proposal
that leptin indirectly regulates POMC neurons via AgRP/
NPY-GABAergic collaterals. The degree to which this accounts
for leptin’s antiobesity effects, however, has been unclear, espe-
cially because deletion of LEPRs from AgRP neurons produces
only a small disturbance in energy balance (van de Wall et al.,
2008).
In the present study, we show that the above-mentioned effect
(i.e., leptin-mediated reduction of IPSC frequency in POMC
neurons) is mediated by LEPRs on presynaptic GABAergic
neurons and that LEPRs on postsynaptic POMC neurons play
no role. Furthermore, our data indicate that LEPRs on non-
AgRP GABAergic neurons are predominantly responsible for
this effect. The following three findings support this view: (1) lep-
tin-mediated reduction of IPSC frequency is minimally affected
when LEPRs are deleted from AgRP neurons (Agrp-ires-Cre,
Leprlox/loxmice), but is totally abrogated when LEPRs are deleted
from all GABAergic neurons (Vgat-ires-Cre, Leprlox/lox mice, Fig-
ure 5B); (2) this response is unimpaired in mice that cannot
release GABA from AgRP neurons (Agrp-ires-Cre, Vgatlox/lox
mice, Figure 5B); and (3) deletion of LEPRs from GABAergic
neurons (Vgat-ires-Cre, Leprlox/lox mice) markedly increases
IPSC frequency and amplitude in POMC neurons while, in
contrast, no effect is seen when LEPRs are deleted from AgRP
neurons (Agrp-ires-Cre, Leprlox/lox mice, Figure 6A). These
results clearly attest to the important role played by non-AgRP
neurons in leptin-mediated disinhibition of POMC neurons and,
of interest, are congruent with the presence of massive obesity
versus minimal obesity, respectively, in Vgat-ires-Cre, Leprlox/lox
mice (Figure 2) versusAgrp-ires-Cre, Leprlox/loxmice (van deWall
et al., 2008). One notable caveat on the above analysis is the
possibility of compensation as was observed after diphtheria
toxin-mediated ablation of AGRP neurons in neonates (Luquet
et al., 2005). If such compensation were to occur after genetic
deletion of LEPRs in AgRP neurons, then our approach could
underestimate the contribution of AgRP GABAergic neurons.
However, given that toxin ablation kills neurons while LEPR
deletion, on the other hand, leaves neurons largely intact, it is
unclear whether similar degrees or forms of compensation
should be expected. To summarize, our results and those of
others (Cowley et al., 2001) demonstrate that leptin reduces
inhibitory tone to POMC neurons. This effect is mediated by
LEPRs on presynaptic GABAergic neurons, some of which
may express AgRP and many of which probably do not.
Leptin Action via GABAergic Neurons: Issues
and Implications
It has previously been established that leptin’s antiobesity
effects require Tyr1138 of the LEPR, which allows for phosphory-
lation-dependent docking and activation (via subsequent
phosphorylation) of the latent transcription factor STAT3 (Bates
et al., 2003). Of note, marked obesity, similar in magnitude to
that observed in mice totally lacking LEPRs, occurs in mice
homozygous for the LeprS1138 allele. This requirement for
Tyr1138 strongly implicates STAT3-mediated gene expressionNeuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc. 151
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Leptin Action via Presynaptic GABAergic Neuronsin leptin’s antiobesity effects. The relevant downstream tran-
scriptional targets, however, are not yet known but are of great
interest. Prior studies have focused on the Pomc gene (Mu¨nz-
berg et al., 2003). However, given the important role of leptin-
responsive GABAergic neurons in regulating body weight,
most of which do not express AgRP and none of which appear
to express POMC (Figure 3; Ovesjo¨ et al., 2001; Yee et al.,
2009; and for a dissenting view, Hentges et al., 2009), it will be
important to reexamine this issue. Perhaps the key leptin-
responsive target genes do not encode neuropeptides but
instead encode proteins involved in modulating GABA release
or possibly proteins that regulate plasticity of GABAergic
synapses (Pinto et al., 2004).
Related to the above, it has been reported that leptin’s ability
to acutely decrease IPSC frequency in POMC neurons is unal-
tered in LeprS1138/S1138 mice (Mu¨nzberg et al., 2007). Specifi-
cally, intact inhibition was observed in two out of five POMC
neurons (see Figure 3B of that prior study). Given that
LeprS1138/S1138 mice are massively obese, this suggests that lep-
tin-mediated acute suppression of IPSC frequency in POMC
neurons by itself cannot prevent obesity and in addition, that it
is not dependent on STAT3-mediated signaling. Alternatively,
acute leptin suppression of IPSC frequency may still play an
important role as we hypothesize but given the above this role
in regulating body weight may require intact STAT3 signaling
as a necessary precondition. Resolution of these issues will
require further investigation.
Finally, the subcellular site of action andmolecular mechanism
by which leptin modulates GABA release is unclear. Of interest,
acute and chronic leptin modulation of GABA release, at least as
detected in vitro in brain slices, is entirely independent of action
potentials (i.e., it occurs in the presence of TTX) (Figure S4A and
Figure 6A; Cowley et al., 2001; Pinto et al., 2004). This, combined
with our observation that leptin works on presynaptic GABAergic
neurons to produce its effects, raises the distinct possibility that
GABAergic axon terminals are the ultimate subcellular site of
action for leptin’s effects. Whether this involves transcription
and/or translation of proteins that subsequently affect the func-
tion of axon terminals or alternatively, leptin receptor signaling
pathways that are self-contained within axon terminals, is pres-
ently unknown. Given the key role of leptin action on GABAergic
neurons, further studies will be needed to address these inter-
esting possibilities.
EXPERIMENTAL PROCEDURES
Animal Care
Care of all animals and procedures was approved by the Beth Israel
Deaconess Medical Center Institutional Animal Care and Use Committee.
Generation of Vgat-ires-Cre and Vglut2-ires-Cre Mice
Vgat-ires-Cre and Vglut2-ires-Cre knockin mice were generated by gene
targeting by using the same approach as described previously (Tong et al.,
2008). For details see Supplemental Experimental Procedures.
Electrophysiological Studies
Slice Preparation and Whole-Cell Recordings
Brain slices were prepared from young adult mice (5–7 weeks old) as
described previously (Dhillon et al., 2006) with the exception that 300 mM thick
coronal sections were cut with a Leica VT1000S Vibratome.152 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.Measuring Inhibitory and Excitatory Postsynaptic Currents
IPSCs and EPSCs were measured in whole-cell voltage-clamp mode with a
holding potential of 60 mV. The internal recording solution contained
140 mM CsCl, 1 mM BAPTA, 10 mM HEPES, 5 mM MgCl2, 2 mM Mg-ATP,
and 0.3 mM Na-GTP (pH 7.35 with NaOH). Currents were amplified, filtered
at 1 kHz, and digitized at 20 kHz. EPSCs were measured in the presence of
100 mM picrotoxin. IPSCs were measured in the presence of 10 mM NBQX +
50 mM D,L-APV or 1 mM kynurenate. Miniature EPSCs and IPSCs were
recorded with 1 mm tetrodotoxin in aCSF recording solution. Frequency and
peak amplitude were measured by using the Mini Analysis program (Synapto-
soft, Inc.). Cumulative probability distribution for mIPSC amplitudes was
measured for 3 min periods (Figure 6A).
Measuring Membrane Potential and Firing Rate
Membrane potential and firing rate were measured by whole-cell current-
clamp recordings from POMC neurons in brain slices from Leprlox/lox mice
and Vgat-ires-Cre, Leprlox/lox mice. Recording electrodes had resistances of
2.5–4 MU when filled with the K-gluconate internal solution (128 mM K-gluco-
nate, 10 mM HEPES, 1 mM EGTA, 10 mM KCl, 1 mM MgCl2, 0.3 mM CaCl2,
2 mM Mg-ATP, and 0.3 mM Na-GTP, pH 7.35 with KOH).SUPPLEMENTAL INFORMATION
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doi:10.1016/j.neuron.2011.05.028.ACKNOWLEDGMENTS
We would like to thank members of the Lowell laboratory for helpful discus-
sions; C.B. Saper, C. Bjorbaek, and B.P. Bean for advice; J.K. Elmquist and
D.P. Olson for comments on the manuscript; and M. Herman for help with
statistics. This work was supported by grants from the National Institute of
Health/National Institute of Diabetes and Digestive and Kidney Diseases
(R01 DK089044, R01 DK075632, P30 DK046200, and P30 DK057521 to
B.B.L; PO1DK26687 and U54HD058155 to S.C.; F32 DK078478 to L.V.).
Accepted: May 10, 2011
Published: July 13, 2011
REFERENCES
Acuna-Goycolea, C., Tamamaki, N., Yanagawa, Y., Obata, K., and van den
Pol, A.N. (2005). Mechanisms of neuropeptide Y, peptide YY, and pancreatic
polypeptide inhibition of identified green fluorescent protein-expressing GABA
neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 25,
7406–7419.
Ahima, R.S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier,
E., and Flier, J.S. (1996). Role of leptin in the neuroendocrine response to fast-
ing. Nature 382, 250–252.
Bagnol, D., Lu, X.Y., Kaelin, C.B., Day, H.E., Ollmann, M., Gantz, I., Akil, H.,
Barsh, G.S., and Watson, S.J. (1999). Anatomy of an endogenous antagonist:
relationship between Agouti-related protein and proopiomelanocortin in brain.
J. Neurosci. 19, RC26.
Balthasar, N., Coppari, R., McMinn, J., Liu, S.M., Lee, C.E., Tang, V., Kenny,
C.D., McGovern, R.A., Chua, S.C., Jr., Elmquist, J.K., and Lowell, B.B.
(2004). Leptin receptor signaling in POMC neurons is required for normal
body weight homeostasis. Neuron 42, 983–991.
Balthasar, N., Dalgaard, L.T., Lee, C.E., Yu, J., Funahashi, H., Williams, T.,
Ferreira, M., Tang, V., McGovern, R.A., Kenny, C.D., et al. (2005).
Divergence of melanocortin pathways in the control of food intake and energy
expenditure. Cell 123, 493–505.
Baskin, D.G., Breininger, J.F., and Schwartz, M.W. (1999a). Leptin receptor
mRNA identifies a subpopulation of neuropeptide Y neurons activated by fast-
ing in rat hypothalamus. Diabetes 48, 828–833.
Neuron
Leptin Action via Presynaptic GABAergic NeuronsBaskin, D.G., Hahn, T.M., and Schwartz, M.W. (1999b). Leptin sensitive
neurons in the hypothalamus. Horm. Metab. Res. 31, 345–350.
Bates, S.H., Stearns, W.H., Dundon, T.A., Schubert, M., Tso, A.W., Wang, Y.,
Banks, A.S., Lavery, H.J., Haq, A.K., Maratos-Flier, E., et al. (2003). STAT3
signalling is required for leptin regulation of energy balance but not reproduc-
tion. Nature 421, 856–859.
Berthoud, H.R. (2002). Multiple neural systems controlling food intake and
body weight. Neurosci. Biobehav. Rev. 26, 393–428.
Bewick, G.A., Gardiner, J.V., Dhillo, W.S., Kent, A.S., White, N.E., Webster, Z.,
Ghatei, M.A., and Bloom, S.R. (2005). Post-embryonic ablation of AgRP
neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 19, 1680–
1682.
Bingham, N.C., Anderson, K.K., Reuter, A.L., Stallings, N.R., and Parker, K.L.
(2008). Selective loss of leptin receptors in the ventromedial hypothalamic
nucleus results in increased adiposity and a metabolic syndrome.
Endocrinology 149, 2138–2148.
Cowley, M.A., Smart, J.L., Rubinstein, M., Cerda´n, M.G., Diano, S., Horvath,
T.L., Cone, R.D., and Low, M.J. (2001). Leptin activates anorexigenic POMC
neurons through a neural network in the arcuate nucleus. Nature 411, 480–484.
Dhillon, H., Zigman, J.M., Ye, C., Lee, C.E., McGovern, R.A., Tang, V., Kenny,
C.D., Christiansen, L.M., White, R.D., Edelstein, E.A., et al. (2006). Leptin
directly activates SF1 neurons in the VMH, and this action by leptin is required
for normal body-weight homeostasis. Neuron 49, 191–203.
Elias, C.F., Saper, C.B., Maratos-Flier, E., Tritos, N.A., Lee, C., Kelly, J., Tatro,
J.B., Hoffman, G.E., Ollmann, M.M., Barsh, G.S., et al. (1998). Chemically
defined projections linking the mediobasal hypothalamus and the lateral hypo-
thalamic area. J. Comp. Neurol. 402, 442–459.
Elias, C.F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R.S., Bjorbaek, C., Flier,
J.S., Saper, C.B., and Elmquist, J.K. (1999). Leptin differentially regulates NPY
and POMC neurons projecting to the lateral hypothalamic area. Neuron 23,
775–786.
Elias, C.F., Kelly, J.F., Lee, C.E., Ahima, R.S., Drucker, D.J., Saper, C.B., and
Elmquist, J.K. (2000). Chemical characterization of leptin-activated neurons in
the rat brain. J. Comp. Neurol. 423, 261–281.
Faouzi, M., Leshan, R., Bjo¨rnholm, M., Hennessey, T., Jones, J., and
Mu¨nzberg, H. (2007). Differential accessibility of circulating leptin to individual
hypothalamic sites. Endocrinology 148, 5414–5423.
Figlewicz, D.P., Evans, S.B., Murphy, J., Hoen, M., and Baskin, D.G. (2003).
Expression of receptors for insulin and leptin in the ventral tegmental area/sub-
stantia nigra (VTA/SN) of the rat. Brain Res. 964, 107–115.
Friedman, J.M. (2009). Leptin at 14 y of age: an ongoing story. Am. J. Clin. Nutr.
89, 973S–979S.
Fulton, S., Pissios, P., Manchon, R.P., Stiles, L., Frank, L., Pothos, E.N.,
Maratos-Flier, E., and Flier, J.S. (2006). Leptin regulation of the mesoaccum-
bens dopamine pathway. Neuron 51, 811–822.
Grill, H.J., and Kaplan, J.M. (2002). The neuroanatomical axis for control of
energy balance. Front. Neuroendocrinol. 23, 2–40.
Grill, H.J., Schwartz, M.W., Kaplan, J.M., Foxhall, J.S., Breininger, J., and
Baskin, D.G. (2002). Evidence that the caudal brainstem is a target for the
inhibitory effect of leptin on food intake. Endocrinology 143, 239–246.
Gropp, E., Shanabrough, M., Borok, E., Xu, A.W., Janoschek, R., Buch, T.,
Plum, L., Balthasar, N., Hampel, B., Waisman, A., et al. (2005). Agouti-related
peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8,
1289–1291.
Haskell-Luevano, C., Chen, P., Li, C., Chang, K., Smith, M.S., Cameron, J.L.,
and Cone, R.D. (1999). Characterization of the neuroanatomical distribution of
agouti-related protein immunoreactivity in the rhesus monkey and the rat.
Endocrinology 140, 1408–1415.
Hentges, S.T., Otero-Corchon, V., Pennock, R.L., King, C.M., and Low, M.J.
(2009). Proopiomelanocortin expression in both GABA and glutamate neurons.
J. Neurosci. 29, 13684–13690.
Hill, J.W., Elias, C.F., Fukuda, M., Williams, K.W., Berglund, E.D., Holland,
W.L., Cho, Y.R., Chuang, J.C., Xu, Y., Choi, M., et al. (2010). Direct insulinand leptin action on pro-opiomelanocortin neurons is required for normal
glucose homeostasis and fertility. Cell Metab. 11, 286–297.
Hommel, J.D., Trinko, R., Sears, R.M., Georgescu, D., Liu, Z.W., Gao, X.B.,
Thurmon, J.J., Marinelli, M., and DiLeone, R.J. (2006). Leptin receptor
signaling in midbrain dopamine neurons regulates feeding. Neuron 51, 801–
810.
Horvath, T.L., Naftolin, F., Kalra, S.P., and Leranth, C. (1992). Neuropeptide-Y
innervation of beta-endorphin-containing cells in the rat mediobasal hypothal-
amus: a light and electron microscopic double immunostaining analysis.
Endocrinology 131, 2461–2467.
Horvath, T.L., Bechmann, I., Naftolin, F., Kalra, S.P., and Leranth, C. (1997).
Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate
nucleus: GABAergic and non-GABAergic subpopulations. Brain Res. 756,
283–286.
Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q.,
Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, R.D., et al.
(1997). Targeted disruption of the melanocortin-4 receptor results in obesity
in mice. Cell 88, 131–141.
Leinninger, G.M., and Myers, M.G., Jr. (2008). LRb signals act within a distrib-
uted network of leptin-responsive neurones to mediate leptin action. Acta
Physiol. (Oxf.) 192, 49–59.
Leinninger, G.M., Jo, Y.H., Leshan, R.L., Louis, G.W., Yang, H., Barrera, J.G.,
Wilson, H., Opland, D.M., Faouzi, M.A., Gong, Y., et al. (2009). Leptin acts via
leptin receptor-expressing lateral hypothalamic neurons to modulate the mes-
olimbic dopamine system and suppress feeding. Cell Metab. 10, 89–98.
Leshan, R.L., Louis, G.W., Jo, Y.H., Rhodes, C.J., Mu¨nzberg, H., and Myers,
M.G., Jr. (2009). Direct innervation of GnRH neurons by metabolic- and sexual
odorant-sensing leptin receptor neurons in the hypothalamic ventral premam-
millary nucleus. J. Neurosci. 29, 3138–3147.
Luquet, S., Perez, F.A., Hnasko, T.S., and Palmiter, R.D. (2005). NPY/AgRP
neurons are essential for feeding in adult mice but can be ablated in neonates.
Science 310, 683–685.
Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A., Gu, H.,
Ng, L.L., Palmiter, R.D., Hawrylycz, M.J., Jones, A.R., et al. (2010). A robust
and high-throughput Cre reporting and characterization system for the whole
mouse brain. Nat. Neurosci. 13, 133–140.
Majdic, G., Young, M., Gomez-Sanchez, E., Anderson, P., Szczepaniak, L.S.,
Dobbins, R.L., McGarry, J.D., and Parker, K.L. (2002). Knockout mice lacking
steroidogenic factor 1 are a novel genetic model of hypothalamic obesity.
Endocrinology 143, 607–614.
Matsumoto, A., and Arai, Y. (1978). Morphologic evidence for intranuclear
circuits in the hypothalamic arcuate nucleus. Exp. Neurol. 59, 404–412.
Mercer, J.G., Hoggard, N., Williams, L.M., Lawrence, C.B., Hannah, L.T., and
Trayhurn, P. (1996). Localization of leptin receptor mRNA and the long form
splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by
in situ hybridization. FEBS Lett. 387, 113–116.
Mercer, J.G., Moar, K.M., and Hoggard, N. (1998). Localization of leptin
receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain.
Endocrinology 139, 29–34.
Mizuno, T.M., Kleopoulos, S.P., Bergen, H.T., Roberts, J.L., Priest, C.A., and
Mobbs, C.V. (1998). Hypothalamic pro-opiomelanocortin mRNA is reduced
by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin.
Diabetes 47, 294–297.
Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992). The
cloning of a family of genes that encode the melanocortin receptors.
Science 257, 1248–1251.
Mu¨nzberg, H. (2008). Differential leptin access into the brain—a hierarchical
organization of hypothalamic leptin target sites? Physiol. Behav. 94, 664–669.
Mu¨nzberg, H., Huo, L., Nillni, E.A., Hollenberg, A.N., and Bjørbaek, C. (2003).
Role of signal transducer and activator of transcription 3 in regulation of hypo-
thalamic proopiomelanocortin gene expression by leptin. Endocrinology 144,
2121–2131.Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc. 153
Neuron
Leptin Action via Presynaptic GABAergic NeuronsMu¨nzberg, H., Flier, J.S., and Bjørbaek, C. (2004). Region-specific leptin resis-
tance within the hypothalamus of diet-induced obese mice. Endocrinology
145, 4880–4889.
Mu¨nzberg, H., Jobst, E.E., Bates, S.H., Jones, J., Villanueva, E., Leshan, R.,
Bjo¨rnholm, M., Elmquist, J., Sleeman, M., Cowley, M.A., and Myers, M.G.,
Jr. (2007). Appropriate inhibition of orexigenic hypothalamic arcuate nucleus
neurons independently of leptin receptor/STAT3 signaling. J. Neurosci. 27,
69–74.
Myers, M.G., Jr., Mu¨nzberg, H., Leinninger, G.M., and Leshan, R.L. (2009). The
geometry of leptin action in the brain: more complicated than a simple ARC.
Cell Metab. 9, 117–123.
Myers,M.G., Jr., Leibel, R.L., Seeley, R.J., and Schwartz, M.W. (2010). Obesity
and leptin resistance: distinguishing cause from effect. Trends Endocrinol.
Metab. 21, 643–651.
Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe, C.G. (2000). Z/EG, a double
reporter mouse line that expresses enhanced green fluorescent protein upon
Cre-mediated excision. Genesis 28, 147–155.
Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., and
Barsh, G.S. (1997). Antagonism of central melanocortin receptors in vitro and
in vivo by agouti-related protein. Science 278, 135–138.
Ovesjo¨, M.L., Gamstedt, M., Collin, M., and Meister, B. (2001). GABAergic
nature of hypothalamic leptin target neurones in the ventromedial arcuate
nucleus. J. Neuroendocrinol. 13, 505–516.
Parton, L.E., Ye, C.P., Coppari, R., Enriori, P.J., Choi, B., Zhang, C.Y., Xu, C.,
Vianna, C.R., Balthasar, N., Lee, C.E., et al. (2007). Glucose sensing by POMC
neurons regulates glucose homeostasis and is impaired in obesity. Nature 449,
228–232.
Pinto, S., Roseberry, A.G., Liu, H., Diano, S., Shanabrough, M., Cai, X.,
Friedman, J.M., and Horvath, T.L. (2004). Rapid rewiring of arcuate nucleus
feeding circuits by leptin. Science 304, 110–115.
Scott, M.M., Lachey, J.L., Sternson, S.M., Lee, C.E., Elias, C.F., Friedman,
J.M., and Elmquist, J.K. (2009). Leptin targets in the mouse brain. J. Comp.
Neurol. 514, 518–532.
Shutter, J.R., Graham, M., Kinsey, A.C., Scully, S., Lu¨thy, R., and Stark, K.L.
(1997). Hypothalamic expression of ART, a novel gene related to agouti, is
up-regulated in obese and diabetic mutant mice. Genes Dev. 11, 593–602.
Smart, J.L., Tolle, V., and Low, M.J. (2006). Glucocorticoids exacerbate
obesity and insulin resistance in neuron-specific proopiomelanocortin-defi-
cient mice. J. Clin. Invest. 116, 495–505.
Takahashi, K.A., and Cone, R.D. (2005). Fasting induces a large, leptin-depen-
dent increase in the intrinsic action potential frequency of orexigenic arcuate
nucleus neuropeptide Y/Agouti-related protein neurons. Endocrinology 146,
1043–1047.
Takamori, S. (2006). VGLUTs: ‘exciting’ times for glutamatergic research?
Neurosci. Res. 55, 343–351.
Tong, Q., Ye, C., McCrimmon, R.J., Dhillon, H., Choi, B., Kramer, M.D., Yu, J.,
Yang, Z., Christiansen, L.M., Lee, C.E., et al. (2007). Synaptic glutamate
release by ventromedial hypothalamic neurons is part of the neurocircuitry
that prevents hypoglycemia. Cell Metab. 5, 383–393.154 Neuron 71, 142–154, July 14, 2011 ª2011 Elsevier Inc.Tong, Q., Ye, C.P., Jones, J.E., Elmquist, J.K., and Lowell, B.B. (2008).
Synaptic release of GABA by AgRP neurons is required for normal regulation
of energy balance. Nat. Neurosci. 11, 998–1000.
van de Wall, E., Leshan, R., Xu, A.W., Balthasar, N., Coppari, R., Liu, S.M., Jo,
Y.H., MacKenzie, R.G., Allison, D.B., Dun, N.J., et al. (2008). Collective and
individual functions of leptin receptor modulated neurons controlling metabo-
lism and ingestion. Endocrinology 149, 1773–1785.
van den Pol, A.N., and Cassidy, J.R. (1982). The hypothalamic arcuate nucleus
of rat—a quantitative Golgi analysis. J. Comp. Neurol. 204, 65–98.
van den Pol, A.N., Yao, Y., Fu, L.Y., Foo, K., Huang, H., Coppari, R., Lowell,
B.B., and Broberger, C. (2009). Neuromedin B and gastrin-releasing peptide
excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse
expressing strong Renilla green fluorescent protein in NPY neurons.
J. Neurosci. 29, 4622–4639.
van den Top, M., Lee, K., Whyment, A.D., Blanks, A.M., and Spanswick, D.
(2004). Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypotha-
lamic arcuate nucleus. Nat. Neurosci. 7, 493–494.
Williams, K.W., Margatho, L.O., Lee, C.E., Choi, M., Lee, S., Scott, M.M., Elias,
C.F., and Elmquist, J.K. (2010). Segregation of acute leptin and insulin effects
in distinct populations of arcuate proopiomelanocortin neurons. J. Neurosci.
30, 2472–2479.
Wilson, B.D., Bagnol, D., Kaelin, C.B., Ollmann, M.M., Gantz, I., Watson, S.J.,
and Barsh, G.S. (1999). Physiological and anatomical circuitry between
Agouti-related protein and leptin signaling. Endocrinology 140, 2387–2397.
Wojcik, S.M., Katsurabayashi, S., Guillemin, I., Friauf, E., Rosenmund, C.,
Brose, N., and Rhee, J.S. (2006). A shared vesicular carrier allows synaptic
corelease of GABA and glycine. Neuron 50, 575–587.
Wu, Q., Boyle, M.P., and Palmiter, R.D. (2009). Loss of GABAergic signaling
by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137,
1225–1234.
Xu, A.W., Kaelin, C.B., Morton, G.J., Ogimoto, K., Stanhope, K., Graham, J.,
Baskin, D.G., Havel, P., Schwartz, M.W., and Barsh, G.S. (2005). Effects of
hypothalamic neurodegeneration on energy balance. PLoS Biol. 3, e415.
Yadav, V.K., Oury, F., Suda, N., Liu, Z.-W., Gao, X.-B., Confavreux, C.,
Klemenhagen, K.C., Tanaka, K.F., Gingrich, J.A., Guo, X.E., et al. (2009). A
serotonin-dependent mechanism explains the leptin regulation of bone
mass, appetite, and energy expenditure. Cell 138, 976–989.
Yaswen, L., Diehl, N., Brennan, M.B., and Hochgeschwender, U. (1999).
Obesity in the mouse model of pro-opiomelanocortin deficiency responds to
peripheral melanocortin. Nat. Med. 5, 1066–1070.
Yee, C.L., Wang, Y., Anderson, S., Ekker, M., and Rubenstein, J.L. (2009).
Arcuate nucleus expression of NKX2.1 and DLX and lineages expressing these
transcription factors in neuropeptide Y(+), proopiomelanocortin(+), and tyro-
sine hydroxylase(+) neurons in neonatal and adult mice. J. Comp. Neurol.
517, 37–50.
Zhao, L., Bakke, M., Hanley, N.A., Majdic, G., Stallings, N.R., Jeyasuria, P.,
and Parker, K.L. (2004). Tissue-specific knockouts of steroidogenic factor 1.
Mol. Cell. Endocrinol. 215, 89–94.
